The REACH Study: A Novel Values-Based Intervention to Increase Endocrine Therapy Adherence Among Breast Cancer Survivors
Not Applicable
Completed
- Conditions
- Breast Cancer
- Registration Number
- NCT03980093
- Lead Sponsor
- University of Colorado, Boulder
- Brief Summary
This pilot trial compares two online interventions to improve adherence to anti-hormonal medication among women with the most common form of breast cancer (estrogen receptor-positive).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 88
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Medication adherence assessed by electronic pillbox (Wisepill box) Change from baseline through 6 month follow-up
- Secondary Outcome Measures
Name Time Method Medication nonpersistence assessed by electronic pillbox (Wisepill box) Baseline through 6 month follow-up Intentions to adhere to anti-hormonal medication in the next year and next several years Change from baseline through 6 month follow up Anti-Hormonal Medication Intentions Scale (average score on a 1 to 7 scale; higher=better outcome, e.g., stronger intentions to adhere), adapted from the Health Behavior Intentions Scale
Self-reported medication adherence Change from baseline to 3 and 6 month follow-up Reported anti-hormonal medication pills missed, past 30 days, with a validated self-reported medication adherence item
Positive and negative emotional associations with taking anti-hormonal medication Change from baseline through 6 month follow-up Emotional Attitudes Scale, adapted to focus on anti-hormonal medication
Trial Locations
- Locations (1)
Rocky Mountain Cancer Centers
🇺🇸Greenwood Village, Colorado, United States
Rocky Mountain Cancer Centers🇺🇸Greenwood Village, Colorado, United States